DARIOHEALTH CORP (DRIO) Fundamental Analysis & Valuation

NASDAQ:DRIO • US23725P3082

Current stock price

7.2 USD
-0.21 (-2.83%)
Last:

This DRIO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DRIO Profitability Analysis

1.1 Basic Checks

  • In the past year DRIO has reported negative net income.
  • DRIO had a negative operating cash flow in the past year.
  • In the past 5 years DRIO always reported negative net income.
  • DRIO had a negative operating cash flow in each of the past 5 years.
DRIO Yearly Net Income VS EBIT VS OCF VS FCFDRIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • The Return On Assets of DRIO (-31.52%) is worse than 60.00% of its industry peers.
  • With a Return On Equity value of -49.53%, DRIO is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -31.52%
ROE -49.53%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
DRIO Yearly ROA, ROE, ROICDRIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

  • DRIO has a Gross Margin (56.86%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of DRIO has grown nicely.
  • The Profit Margin and Operating Margin are not available for DRIO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
DRIO Yearly Profit, Operating, Gross MarginsDRIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. DRIO Health Analysis

2.1 Basic Checks

  • DRIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for DRIO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DRIO Yearly Shares OutstandingDRIO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
DRIO Yearly Total Debt VS Total AssetsDRIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • DRIO has an Altman-Z score of -5.06. This is a bad value and indicates that DRIO is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -5.06, DRIO is doing worse than 74.29% of the companies in the same industry.
  • A Debt/Equity ratio of 0.41 indicates that DRIO is not too dependend on debt financing.
  • DRIO has a Debt to Equity ratio of 0.41. This is in the lower half of the industry: DRIO underperforms 68.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z -5.06
ROIC/WACCN/A
WACC10.95%
DRIO Yearly LT Debt VS Equity VS FCFDRIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 4.55 indicates that DRIO has no problem at all paying its short term obligations.
  • DRIO's Current ratio of 4.55 is amongst the best of the industry. DRIO outperforms 82.86% of its industry peers.
  • DRIO has a Quick Ratio of 4.02. This indicates that DRIO is financially healthy and has no problem in meeting its short term obligations.
  • DRIO has a better Quick ratio (4.02) than 82.86% of its industry peers.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 4.02
DRIO Yearly Current Assets VS Current LiabilitesDRIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DRIO Growth Analysis

3.1 Past

  • DRIO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.60%, which is quite impressive.
EPS 1Y (TTM)44.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.56%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-31.21%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.28% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, DRIO will show a very strong growth in Revenue. The Revenue will grow by 64.91% on average per year.
EPS Next Y34.77%
EPS Next 2Y29.84%
EPS Next 3Y28.26%
EPS Next 5Y21.28%
Revenue Next Year17.48%
Revenue Next 2Y31.68%
Revenue Next 3Y34.04%
Revenue Next 5Y64.91%

3.3 Evolution

DRIO Yearly Revenue VS EstimatesDRIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
DRIO Yearly EPS VS EstimatesDRIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -200 -400 -600 -800

More info and screens

Find the best growth stocksShow best growing peers

1

4. DRIO Valuation Analysis

4.1 Price/Earnings Ratio

  • DRIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year DRIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRIO Price Earnings VS Forward Price EarningsDRIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRIO Per share dataDRIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • DRIO's earnings are expected to grow with 28.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.84%
EPS Next 3Y28.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DRIO Dividend Analysis

5.1 Amount

  • No dividends for DRIO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DRIO Fundamentals: All Metrics, Ratios and Statistics

DARIOHEALTH CORP

NASDAQ:DRIO (4/23/2026, 8:04:04 PM)

7.2

-0.21 (-2.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-19
Earnings (Next)05-12
Inst Owners10.5%
Inst Owner Change0%
Ins Owners11.12%
Ins Owner Change0%
Market Cap52.56M
Revenue(TTM)N/A
Net Income(TTM)-37.11M
Analysts81.82
Price Target19.18 (166.39%)
Short Float %1.15%
Short Ratio3.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.8%
Min EPS beat(2)24.37%
Max EPS beat(2)159.22%
EPS beat(4)3
Avg EPS beat(4)59.87%
Min EPS beat(4)-17.64%
Max EPS beat(4)159.22%
EPS beat(8)7
Avg EPS beat(8)49.83%
EPS beat(12)9
Avg EPS beat(12)35%
EPS beat(16)11
Avg EPS beat(16)28.68%
Revenue beat(2)0
Avg Revenue beat(2)-18.56%
Min Revenue beat(2)-23.78%
Max Revenue beat(2)-13.34%
Revenue beat(4)1
Avg Revenue beat(4)-11.91%
Min Revenue beat(4)-23.78%
Max Revenue beat(4)0.92%
Revenue beat(8)1
Avg Revenue beat(8)-11.12%
Revenue beat(12)3
Avg Revenue beat(12)-10.13%
Revenue beat(16)5
Avg Revenue beat(16)-8.21%
PT rev (1m)4.44%
PT rev (3m)3.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.85%
EPS NY rev (1m)-35.74%
EPS NY rev (3m)66.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.13
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 47.7
EV/EBITDA N/A
EPS(TTM)-6.87
EYN/A
EPS(NY)-4.48
Fwd EYN/A
FCF(TTM)-3.69
FCFYN/A
OCF(TTM)-3.67
OCFYN/A
SpS3.39
BVpS10.26
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -31.52%
ROE -49.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.86%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
F-Score5
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.89%
Cap/Sales 0.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 4.02
Altman-Z -5.06
F-Score5
WACC10.95%
ROIC/WACCN/A
Cap/Depr(3y)8.55%
Cap/Depr(5y)19.33%
Cap/Sales(3y)1.81%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.56%
EPS Next Y34.77%
EPS Next 2Y29.84%
EPS Next 3Y28.26%
EPS Next 5Y21.28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-31.21%
Revenue Next Year17.48%
Revenue Next 2Y31.68%
Revenue Next 3Y34.04%
Revenue Next 5Y64.91%
EBIT growth 1Y33.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.05%
EBIT Next 3Y25.14%
EBIT Next 5Y16.13%
FCF growth 1Y14.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.57%
OCF growth 3YN/A
OCF growth 5YN/A

DARIOHEALTH CORP / DRIO Fundamental Analysis FAQ

What is the fundamental rating for DRIO stock?

ChartMill assigns a fundamental rating of 2 / 10 to DRIO.


Can you provide the valuation status for DARIOHEALTH CORP?

ChartMill assigns a valuation rating of 1 / 10 to DARIOHEALTH CORP (DRIO). This can be considered as Overvalued.


How profitable is DARIOHEALTH CORP (DRIO) stock?

DARIOHEALTH CORP (DRIO) has a profitability rating of 1 / 10.


Can you provide the financial health for DRIO stock?

The financial health rating of DARIOHEALTH CORP (DRIO) is 4 / 10.


Can you provide the expected EPS growth for DRIO stock?

The Earnings per Share (EPS) of DARIOHEALTH CORP (DRIO) is expected to grow by 34.77% in the next year.